CVS Health (CVS) Tops Q2 EPS by 75c; raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $93.47 -1.07%
EPS Growth %: +3.1%
Financial Fact:
Weighted average basic common shares outstanding (in shares): 1.07B
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +3.1%
Financial Fact:
Weighted average basic common shares outstanding (in shares): 1.07B
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.58, $0.75 better than the analyst estimate of $1.83. Revenue for the quarter came in at $106.1 billion versus the consensus estimate of $100.03 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.90-$8.10, versus the consensus of $7.45.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
- Stem notified of NYSE noncompliance over market cap and equity
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
